Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: systematic analysis from the global burden of disease study 2019

By sjmartinez • June 29, 2024

Danpanichkul P, Suparan K, Dutta P, Kaeosri C, Sukphutanan B, Pang Y, Kulthamrongsri N, Jaisa-Aad M, Ng CH, Teng M, Nakano M, Morishita A, Alkhouri N, Yang JD, Chen VL, Kim D, Fallon MB, Diaz LA, Arab JP, Mantzoros CS, Noureddin M, Lazarus JV, Wijarnpreecha K. Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: systematic analysis from the global burden of disease study 2019. Metabolism. 2024 Jun 26:155958. doi: 10.1016/j.metabol.2024.155958. Epub ahead of print. PMID: 38942169.

Tags: Cedars Sinai DoM, Digestive Diseases, Disparity, Epidemiology, Liver disease, MASLD, Metabolic syndrome, NAFLD, non-alcoholic fatty liver disease

Comparative Predictors of Mortality Risk in Contemporary Patients Referred for Stress Myocardial Perfusion Imaging

Rozanski A, Gransar H, Miller RJH, Han D, Hayes SW, Friedman JD, Thomson L, Lavie CJ, Berman DS. Comparative Predictors of Mortality Risk in Contemporary[...]

Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care

Countouris M, Mahmoud Z, Cohen JB, Crousillat D, Hameed AB, Harrington CM, Hauspurg A, Honigberg MC, Lewey J, Lindley K, McLaughlin MM, Sachdev N, Sarma[...]

Chemopreventive strategies for sporadic colorectal cancer: a narrative review

Monson S, Chen PJ, Gangi A, Waters K, Billet S, Hendifar A, Lu S, Zell JA, Gong J. Chemopreventive strategies for sporadic colorectal cancer: a[...]